Lorinol HS Eye Drop contains Loteprednol etabonate 5mg, a corticosteroid indicated for the treatment of ocular inflammation and pain associated with allergic conjunctivitis, postoperative inflammation, and other steroid-responsive inflammatory conditions of the eye. Loteprednol etabonate is a potent anti-inflammatory agent that works by inhibiting the release of inflammatory mediators, thereby reducing redness, swelling, and discomfort. Lorinol HS Eye Drop is formulated to provide targeted relief with minimal systemic absorption, reducing the risk of systemic corticosteroid-related side effects. It is typically prescribed for short-term use under the supervision of an ophthalmologist to manage acute inflammatory episodes. Patients should be advised to avoid contamination of the dropper tip and to adhere strictly to the prescribed dosage to prevent potential adverse effects such as increased intraocular pressure, delayed wound healing, or secondary ocular infections. Regular monitoring of intraocular pressure is recommended during prolonged therapy. Lorinol HS Eye Drop is contraindicated in patients with viral, fungal, or mycobacterial ocular infections and those with known hypersensitivity to any component of the formulation. This medication should be used cautiously in patients with glaucoma or a history of corticosteroid-induced ocular hypertension.